Scientists have developed a tiny, portable personal blood testing laboratory that sends data through mobile phone

Mar 19, 2013
This implant measures about 14mm and comprises five sensors, a coil for wireless power as well a miniaturized electronics for radio communication. Credit: EPFL

Humans are veritable chemical factories—we manufacture thousands of substances and transport them, via our blood, throughout our bodies. Some of these substances can be used as indicators of our health status. A team of EPFL scientists has developed a tiny device that can analyze the concentration of these substances in the blood. Implanted just beneath the skin, it can detect up to five proteins and organic acids simultaneously, and then transmit the results directly to a doctor's computer. This method will allow a much more personalized level of care than traditional blood tests can provide. Health care providers will be better able to monitor patients, particularly those with chronic illness or those undergoing chemotherapy. The prototype, still in the experimental stages, has demonstrated that it can reliably detect several commonly traced substances.

The research results will be published and presented March 20, 2013 in Europe's largest electronics conference, DATE 13.

This video is not supported by your browser at this time.
EPFL scientists have developed a tiny, portable personal blood testing laboratory: a minuscule device implanted just under the skin provides an immediate analysis of substances in the body, and a radio module transmits the results to a doctor over the cellular phone network. This feat of miniaturization has many potential applications, including monitoring patients undergoing chemotherapy. Credit: EPFL

Three cubic millimeters of technology

The device was developed by a team led by EPFL scientists Giovanni de Micheli and Sandro Carrara. The implant, a real gem of concentrated technology, is only a few cubic millimeters in volume but includes five sensors, a and a power delivery system. Outside the body, a battery patch provides 1/10 watt of power, through the patient's skin – thus there's no need to operate every time the battery needs changing.

Information is routed through a series of stages, from the patient's body to the doctor's computer screen. The implant emits over a safe frequency. The patch collects the data and transmits them via Bluetooth to a mobile phone, which then sends them to the doctor over the .

This implant measures about 14mm and comprises five sensors, a coil for wireless power as well a miniaturized electronics for radio communication. Credit: EPFL

A system that can detect numerous substances

Great care was taken in developing the sensors. To capture the targeted substance in the body – such as , glucose, or ATP – each sensor's surface is covered with an enzyme. "Potentially, we could detect just about anything," explains De Micheli. "But the enzymes have a limited lifespan, and we have to design them to last as long as possible." The enzymes currently being tested are good for about a month and a half; that's already long enough for many applications. "In addition, it's very easy to remove and replace the implant, since it's so small."

The electronics were a considerable challenge as well. "It was not easy to get a system like this to work on just a tenth of a watt," de Micheli explains. The researchers also struggled to design the minuscule electrical coil that receives the power from the patch.

Towards personalized chemotherapy

The implant could be particularly useful in chemotherapy applications. Currently, oncologists use occasional blood tests to evaluate their patients' tolerance to a particular treatment dosage. In these conditions, it is very difficult to administer the optimal dose. De Micheli is convinced his system will be an important step towards better, more personalized medicine. "It will allow direct and continuous monitoring based on a patient's individual tolerance, and not on age and weight charts or weekly blood tests."

In patients with , the implants could send alerts even before symptoms emerge, and anticipate the need for medication. "In a general sense, our system has enormous potential in cases where the evolution of a pathology needs to be monitored or the tolerance to a treatment tested."

The prototype has already been tested in the laboratory for five different substances, and proved as reliable as traditional analysis methods. The project brought together eletronics experts, computer scientists, doctors and biologists from EPFL, the Istituto di Ricerca di Bellinzona, EMPA and ETHZ. It is part of the Swiss Nano-Tera program, whose goal is to encourage interdisciplinary research in the environmental and medical fields. Researchers hope the system will be commercially available within 4 years.

Explore further: LG Chem's super-efficient OLED lighting has life of 40,000 hours

Related Stories

The right dose for oncology

Mar 04, 2013

EPFL researchers develop a tool for oncologists using the electrical signature of cancer cells to get just the right treatment dosage for each patient.

Sensor in artery measures blood pressure

Jan 05, 2009

(PhysOrg.com) -- High blood pressure can be a trial of patience for doctors and for sufferers, whose blood pressure often has to be monitored over a long time until it can be regulated. This will now be made ...

Sensor chip for monitoring tumors

Aug 26, 2011

A chip implant may soon be capable of monitoring tumors that are difficult to operate on or growing slowly. Medical engineers at Technische Universitaet Muenchen have developed an electronic sensor chip that can determine ...

Recommended for you

Facebook dressed down over 'real names' policy

6 hours ago

Facebook says it temporarily restored hundreds of deleted profiles of self-described drag queens and others, but declined to change a policy requiring account holders to use their real names rather than drag names such as ...

Apple iOS 8 software bug affects health apps

6 hours ago

A bug in Apple's new iOS 8 software for mobile devices is prompting the company to withhold apps that use a highly touted feature for keeping track of fitness and health data.

Yelp to pay US fine for child privacy violation

13 hours ago

Online ratings operator Yelp agreed to pay $450,000 to settle US charges that it illegally collected data on children, in violation of privacy laws, officials said Wednesday.

User comments : 2

Adjust slider to filter visible comments by rank

Display comments: newest first

Rados
not rated yet Mar 20, 2013
Looks like almost complete, doctor-redudant, system, however i guess there is obstacle when it comes to data interpretation and it still need a human factor and it is also matter of time before some algorithm replaces him
SYinc
not rated yet Apr 12, 2013
Hmmm - nextgen employer drug-testing perhaps?